Skip to main content
EDIT filings

Corporate insider profile

Linda Burkly Filing Activity

Latest reported as EVP, CHIEF SCIENTIFIC OFFICER of Editas Medicine, Inc. (EDIT).

Purchase filings
0
Reported companies
1
Net open-market value
-$1,974.50
Latest transaction
Jun 3, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 3, 2026Editas Medicine, Inc. (EDIT)EVP, CHIEF SCIENTIFIC OFFICERSale731$2.70$1,975